The JenaValve ALIGN-AR Pivotal Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 180 participants.

Also called NCT04415047

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04415047
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04415047. Allocation not applicable; no masking; primary purpose treatment. Start 2020-05-22 (actual); primary completion 2023-08-29 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The JenaValve ALIGN-AR Pivotal Trial
Acronym
ALIGN-AR
Condition
Aortic Regurgitation
Condition
Aortic Valve Insufficiency
Condition
Aortic Insufficiency
Condition
Aortic Valve Disease
Intervention (Device)
JenaValve Trilogy Heart Valve System
Lead sponsor
JenaValve Technology, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04415047
Content hash
c18f7e3c2c464c78197c365ef79b9d91a54fc2836bdf477c7005456b1e83c144